LifeStance Health Group (NASDAQ:LFST) Hits New 1-Year Low at $4.69

LifeStance Health Group, Inc. (NASDAQ:LFST) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $4.69 and last traded at $4.70, with a volume of 709714 shares traded. The stock had previously closed at $4.81.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on LFST. Jefferies Financial Group increased their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Morgan Stanley restated an “overweight” rating and set a $10.00 price objective on shares of LifeStance Health Group in a research report on Monday, April 22nd. The Goldman Sachs Group upped their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, Barclays upped their price objective on LifeStance Health Group from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Thursday, February 29th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, LifeStance Health Group presently has an average rating of “Hold” and an average target price of $8.80.

LifeStance Health Group Stock Up 0.4 %

The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market capitalization of $1.87 billion, a P/E ratio of -10.17 and a beta of 1.23. The firm has a 50-day simple moving average of $6.03 and a 200 day simple moving average of $6.50.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The company had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. During the same period last year, the company earned ($0.09) earnings per share. The firm’s revenue was up 18.9% compared to the same quarter last year. On average, equities research analysts forecast that LifeStance Health Group, Inc. will post -0.26 EPS for the current year.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Danish J. Qureshi sold 12,965 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $5.93, for a total value of $76,882.45. Following the completion of the sale, the insider now owns 4,911,050 shares of the company’s stock, valued at $29,122,526.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Paula Cipollone sold 48,278 shares of LifeStance Health Group stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $7.22, for a total transaction of $348,567.16. Following the transaction, the insider now owns 239,915 shares of the company’s stock, valued at $1,732,186.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Danish J. Qureshi sold 12,965 shares of LifeStance Health Group stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $5.93, for a total value of $76,882.45. Following the transaction, the insider now directly owns 4,911,050 shares in the company, valued at approximately $29,122,526.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,100,681 shares of company stock valued at $24,087,326. Company insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Hedge funds have recently bought and sold shares of the business. DekaBank Deutsche Girozentrale bought a new stake in LifeStance Health Group during the third quarter worth $34,000. Sunbelt Securities Inc. bought a new stake in shares of LifeStance Health Group in the third quarter valued at $34,000. Bessemer Group Inc. raised its stake in shares of LifeStance Health Group by 43.4% in the first quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock valued at $56,000 after buying an additional 2,768 shares during the period. Allen Investment Management LLC bought a new stake in shares of LifeStance Health Group in the first quarter valued at $79,000. Finally, Assetmark Inc. raised its stake in shares of LifeStance Health Group by 21.6% in the fourth quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock valued at $93,000 after buying an additional 2,114 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.